The global Gel Card market size is predicted to grow from US$ 143 million in 2025 to US$ 218 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
A Gel Card is a diagnostic tool used in immunohematology, particularly in blood typing and crossmatching procedures. It consists of a small plastic card containing multiple wells, each filled with a gel matrix. The gel matrix helps to separate and capture cells based on their reaction with specific antibodies or antigens.
Market Overview:
The Gel Card market has seen significant growth due to advancements in diagnostic technologies, increased demand for blood transfusion safety, and the rising need for precise and efficient testing methods in immunohematology. The use of Gel Cards is driven by the growing awareness of the importance of blood compatibility testing, especially in transfusion medicine.
Key Market Drivers:
Rising Demand for Safe Blood Transfusions: With an increasing number of surgeries, trauma cases, and medical treatments requiring blood transfusions, there is a greater need for safe and compatible blood transfusions. Gel Cards offer a reliable way to test compatibility between donors and recipients, thus reducing the risk of transfusion reactions.
Technological Advancements: The continuous improvement in gel-based diagnostic technologies, such as more accurate antibody detection and better automation, drives the growth of the Gel Card market. These advancements improve the speed, accuracy, and reliability of blood typing and compatibility testing.
Increasing Prevalence of Blood Disorders: The rising incidence of blood-related diseases (such as anemia, thalassemia, sickle cell disease) and the growing need for frequent blood transfusions contribute to the increasing demand for blood testing and Gel Card products.
Government Regulations and Policies: Governments and regulatory bodies are placing greater emphasis on improving the safety of blood transfusions, which leads to a rise in demand for reliable blood typing technologies, such as Gel Cards.
Population Growth and Aging: The global population, especially in developed and developing countries, is aging, leading to an increase in healthcare requirements, including blood transfusions. This, in turn, boosts the demand for Gel Card products.
Market Challenges:
High Initial Cost: While Gel Cards provide accurate and reliable results, their cost might be higher compared to other traditional blood typing methods, which could be a barrier for smaller labs and hospitals in developing regions.
Competition: The market for blood typing and immunohematology is competitive, with several companies offering alternative diagnostic technologies and reagents, such as tube testing or microplate-based assays.
In conclusion, the Gel Card market is expanding due to technological advancements, an increasing focus on blood safety, and the rising demand for efficient and accurate diagnostic solutions in immunohematology.
LP Information, Inc. (LPI) ' newest research report, the “Gel Card Industry Forecast” looks at past sales and reviews total world Gel Card sales in 2024, providing a comprehensive analysis by region and market sector of projected Gel Card sales for 2025 through 2031. With Gel Card sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gel Card industry.
This Insight Report provides a comprehensive analysis of the global Gel Card landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gel Card portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gel Card market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gel Card and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gel Card.
This report presents a comprehensive overview, market shares, and growth opportunities of Gel Card market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Grouping Gel Card
Crossmatch Gel Card
Antibody Screening Gel Card
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Grifols
Fortress Diagnostics
Ortho Clinical Diagnostics
ISLAB
Biorex Diagnostics
Bio-Rad
Tulip Diagnostics
KangJia
Aikang MedTech
Zhuhai Ideal Biotech
BSBE
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gel Card market?
What factors are driving Gel Card market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gel Card market opportunities vary by end market size?
How does Gel Card break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook